Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
The COVID-19 Rapid Antigen Test Kit is an in-vitro immunochromatographic assay for the qualitative detection of SARS-CoV-2 viral nucleoprotein antigens in Fluorescence Immunochromatography, Colloidal Gold Immunochromatography and Latex Immunochromatography specimens from individuals suspected of COVID-19 by their healthcare provider.
Due to the COVID-19 pandemic, the global COVID-19 Rapid Antigen Test Kits market size is estimated to be worth US$ 28030 million in 2021 and is forecast to a readjusted size of US$ 14150 million by 2028 with a CAGR of -21.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Rapid Antigen Test Kits market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Rapid Antigen Test Kits landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global key players of COVID-19 rapid antigen test kits include Abbott, Quidel, ACCESS BIO, CTK Biotech, etc. Global top five manufacturers hold a share over 47%. Europe is the largest market of COVID-19 rapid antigen test kits holds a share over 48%. In terms of product, fluorescence immunochromatography is the largest segment, with a share over 84%.And in terms of application, the largest application is hospital, with a share over 69%.
This report focuses on COVID-19 Rapid Antigen Test Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Rapid Antigen Test Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.
Global COVID-19 Rapid Antigen Test Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segment by Application
Hospital
Home
School
Third-Party Detection Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
Jinwofu Bioengineering Technology
Phase Scientific
Due to the COVID-19 pandemic, the global COVID-19 Rapid Antigen Test Kits market size is estimated to be worth US$ 28030 million in 2021 and is forecast to a readjusted size of US$ 14150 million by 2028 with a CAGR of -21.7% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Rapid Antigen Test Kits market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Rapid Antigen Test Kits landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Global key players of COVID-19 rapid antigen test kits include Abbott, Quidel, ACCESS BIO, CTK Biotech, etc. Global top five manufacturers hold a share over 47%. Europe is the largest market of COVID-19 rapid antigen test kits holds a share over 48%. In terms of product, fluorescence immunochromatography is the largest segment, with a share over 84%.And in terms of application, the largest application is hospital, with a share over 69%.
This report focuses on COVID-19 Rapid Antigen Test Kits volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Rapid Antigen Test Kits market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South Korea, etc.
Global COVID-19 Rapid Antigen Test Kits Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Fluorescence Immunochromatography
Colloidal Gold Immunochromatography
Latex Immunochromatography
Others
Segment by Application
Hospital
Home
School
Third-Party Detection Institution
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Quidel
ACCESS BIO
CTK Biotech
SD Biosensor
Ellume
InBios
Celltrion
AESKU.GROUP
ROCHE
BD
OraSure Technologies
Clip Health
LumiraDx
Princeton BioMeditech Corporation
RapiGEN Inc.
Orient Gene
Wondfo Biotech
Ihealth (Andon Health)
Wantai BioPharm
Biotest Biotech
Shenzhen YHLO Biotech
Vazyme Biotech
EasyDiagnosis Biomedicine
Beijing Hotgen Biotech
Assure Tech
Hangzhou AllTest Biotech
ACON Biotech
BGI Genomics
Lepu Medical Technology
Jinwofu Bioengineering Technology
Phase Scientific
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
